Modified Glasgow prognostic score in patients with incurable stage IV colorectal cancer

American Journal of Surgery

Volumn 206, Issue 2, 2013, Pages 234-240

  Kishiki, Tomokazu ^a   Masaki, Tadahiko ^a   Matsuoka, Hiroyoshi ^a   Kobayashi, Takaaki ^a   Suzuki, Yutaka ^a   Abe, Nobutsugu ^a   Mori, Toshiyuki ^a   Sugiyama, Masanori ^a  

^a KYORIN UNIVERSITY   (Japan)

Author keywords

Colorectal cancer; Glasgow prognostic score; Inflammation based prognostic score; Stage IV

Indexed keywords

ALBUMIN; C REACTIVE PROTEIN; HEMOGLOBIN;

ADULT; AGED; ARTICLE; CANCER ADJUVANT THERAPY; CANCER PROGNOSIS; CANCER SPECIFIC SURVIVAL; CANCER STAGING; CANCER SURGERY; COLORECTAL CANCER; DISTANT METASTASIS; FEMALE; GLASGOW OUTCOME SCALE; HUMAN; LUNG METASTASIS; MAJOR CLINICAL STUDY; MALE; OVERALL SURVIVAL; PRIORITY JOURNAL; SCORING SYSTEM; SURGICAL MORTALITY;

COLORECTAL CANCER; GLASGOW PROGNOSTIC SCORE; INFLAMMATION-BASED PROGNOSTIC SCORE; STAGE IV;

AGED; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CHEMOTHERAPY, ADJUVANT; COLORECTAL NEOPLASMS; FEMALE; HEMOGLOBINS; HUMANS; KAPLAN-MEIER ESTIMATE; LYMPH NODES; LYMPHATIC METASTASIS; MALE; MULTIVARIATE ANALYSIS; NEOPLASM INVASIVENESS; NEOPLASM STAGING; PREDICTIVE VALUE OF TESTS; PROGNOSIS; RETROSPECTIVE STUDIES; TUMOR MARKERS, BIOLOGICAL;

EID: 84880571731     PISSN: 00029610     EISSN: 18791883     Source Type: Journal    
DOI: 10.1016/j.amjsurg.2012.07.051     Document Type: Article

References (25)

1. S.A. Rosen, J.F. Buell, and A. Yoshida Initial presentation with stage IV colorectal cancer: how aggressive should we be? Arch Surg 135 2000 530 534 discussion 534-5
2. D.C. McMillan An inflammation-based prognostic score and its role in the nutrition-based management of patients with cancer Proc Nutr Soc 67 2008 257 262
3. D.C. McMillan, J.E. Crozier, and K. Canna Evaluation of an inflammation-based prognostic score (GPS) in patients undergoing resection for colon and rectal cancer Int J Colorectal Dis 22 2007 881 886
4. M. Ishizuka, H. Nagata, and K. Takagi Inflammation-based prognostic score is a novel predictor of postoperative outcome in patients with colorectal cancer Ann Surg 246 2007 1047 1051
5. L.M. Forrest, D.C. McMillan, and C.S. McArdle Comparison of an inflammation-based prognostic score (GPS) with performance status (ECOG) in patients receiving platinum-based chemotherapy for inoperable non-small-cell lung cancer Br J Cancer 90 2004 1704 1706
6. G.X. Cai, and S.J. Cai Multi-modality treatment of colorectal liver metastases World J Gastroenterol 18 2012 16 24
7. H.R. Scott, D.C. McMillan, and L.M. Forrest The systemic inflammatory response, weight loss, performance status and survival in patients with inoperable non-small cell lung cancer Br J Cancer 87 2002 264 267
8. D.C. McMillan, H.R. Scott, and W.S. Watson Longitudinal study of body cell mass depletion and the inflammatory response in cancer patients Nutr Cancer 31 1998 101 105
9. C. Miki, N. Konishi, and E. Ojima C-reactive protein as a prognostic variable that reflects uncontrolled up-regulation of the IL-1-IL-6 network system in colorectal carcinoma Dig Dis Sci 49 2004 970 976
10. A.A. Ali, D.C. McMillan, and I.I. Matalka Tumour T-lymphocyte subset infiltration and tumour recurrence following curative resection for colorectal cancer Eur J Surg Oncol 30 2004 292 295
11. K. Canna, P.A. McArdle, and D.C. McMillan The relationship between tumour T-lymphocyte infiltration, the systemic inflammatory response and survival in patients undergoing curative resection for colorectal cancer Br J Cancer 92 2005 651 654
12. D.C. McMillan Systemic inflammation, nutritional status and survival in patients with cancer Curr Opin Clin Nutr Metab Care 12 2009 223 226
13. T. Kobayashi, M. Teruya, and T. Kishiki Inflammation-based prognostic score, prior to neoadjuvant chemoradiotherapy, predicts postoperative outcome in patients with esophageal squamous cell carcinoma Surgery 144 2008 729 735
14. T. Kobayashi, M. Teruya, and T. Kishiki Inflammation-based prognostic score and number of lymph node metastases are independent prognostic factors in esophageal squamous cell carcinoma Dig Surg 27 2010 232 237
15. D.A. Deans, S.J. Wigmore, and H. Gilmour Elevated tumour interleukin-1beta is associated with systemic inflammation: a marker of reduced survival in gastro-oesophageal cancer Br J Cancer 95 2006 1568 1575
16. T. Kobayashi, M. Teruya, and T. Kishiki Elevated C-reactive protein and hypoalbuminemia measured before resection of colorectal liver metastases predict postoperative survival Dig Surg 27 2010 285 290
17. A. Obermair, A. Handisurya, and A. Kaider The relationship of pretreatment serum hemoglobin level to the survival of epithelial ovarian carcinoma patients: a prospective review Cancer 83 1998 726 731
18. J.L. Spivak The blood in systemic disorders Lancet 355 2000 1707 1712
19. G. Mantovani, A. Maccio, and C. Madeddu Quantitative evaluation of oxidative stress, chronic inflammatory indices and leptin in cancer patients: correlation with stage and performance status Int J Cancer 98 2002 84 91
20. G. Mantovani, A. Maccio, and C. Madeddu Serum values of proinflammatory cytokines are inversely correlated with serum leptin levels in patients with advanced stage cancer at different sites J Mol Med (Berl) 79 2001 406 414
21. A. Maccio, C. Madeddu, and D. Massa Hemoglobin levels correlate with interleukin-6 levels in patients with advanced untreated epithelial ovarian cancer: role of inflammation in cancer-related anemia Blood 106 2005 362 367
22. M. Ishizuka, H. Nagata, and K. Takagi Influence of inflammation-based prognostic score on mortality of patients undergoing chemotherapy for far advanced or recurrent unresectable colorectal cancer Ann Surg 250 2009 268 272
23. S. Kopetz, G.J. Chang, and M.J. Overman Improved survival in metastatic colorectal cancer is associated with adoption of hepatic resection and improved chemotherapy J Clin Oncol 27 2009 3677 3683
24. S.R. Alberts, W.L. Horvath, and W.C. Sternfeld Oxaliplatin, fluorouracil, and leucovorin for patients with unresectable liver-only metastases from colorectal cancer: a North Central Cancer Treatment Group phase II study J Clin Oncol 23 2005 9243 9249
25. A. Andreou, T.A. Aloia, and A. Brouquet Recent advances in the curative treatment of colorectal liver metastases Gastrointest Cancer Res 4 Suppl 1 2011 S2 S8